Genscript Biotech Financial Overview
Genscript Biotech's market cap is currently $35.46B. The company's EPS TTM is HK$-0.17123420951999999; its P/E ratio is -24.94; Genscript Biotech is scheduled to report earnings on August 17, 2025, and the estimated EPS forecast is HK$-0.08. See an overview of income statement, balance sheet, and cash flow financials.
